Company: LIMN
Filing Date: 2025-01-16
Form Type: POS AM
Source: 0001104659-25-003835
Chunk: 272

Company: Liminatus Pharma, Inc.
Filing Date: 2025-01-16
Form: POS AM
Chunk 272
---
 from taking actions that may be harmful to other stockholders or making changes to provisions that are intended to protect all stockholders by requiring the affirmative vote of at least 66-2/3% of the total voting power to amend the key provisions of the ParentCo Certificate of Incorporation;

• Blank Check Company . The amendment will eliminate provisions specific to Iris’s status as a blank check company that will serve no purpose following the consummation of the Business Combination; and

• Corporate Opportunity . The removal of the corporate opportunity doctrine provisions would ensure that directors, officers and controlling stockholders will not be able to take advantage of opportunities beneficial to Liminatus for themselves without first disclosing the opportunity to the Liminatus board of directors and giving the Liminatus board of directors the opportunity to decline the opportunity on behalf of Liminatus.

#### Required Vote for Approval
The approval of the ParentCo Charter Proposal requires the affirmative vote of a majority of the votes cast by stockholders present in person or represented by proxy and entitled to vote thereon at the Special Meeting (which would include presence by virtual attendance at the Special Meeting). An abstention will be counted towards the quorum requirement but will not count as a vote cast at the Special Meeting. A broker non-vote will neither be counted towards the quorum requirement (as we believe the ParentCo Charter Proposal will be considered as non-discretionary) nor count as a vote cast in the Special Meeting. The stockholder votes regarding the ParentCo Charter Proposal are advisory votes and are not binding on us or our Board.

#### Recommendation of the Iris Board

### THE IRIS BOARD UNANIMOUSLY RECOMMENDS THAT
<div align='center'>IRIS STOCKHOLDERS VOTE “FOR” THE PARENTCO CHARTER PROPOSAL.

132</div>

TABLE OF CONTENTS

#### PROPOSAL NO. 5 — THE ADVISORY CHARTER PROPOSALS
In connection with the Business Combination, Iris is asking its stockholders to vote upon, on a non-binding advisory basis, proposals to approve certain governance provisions contained in the Proposed ParentCo Certificate of Incorporation. This separate vote is not otherwise required by Delaware law separate and apart from the Charter Proposal. Pursuant to SEC guidance, Iris is submitting these provisions to its stockholders separately for approval, allowing stockholders the opportunity to present their separate views on important governance provisions. However, the stockholder votes regarding these proposals are advisory votes, and are not binding on Iris or